U.S. markets open in 33 minutes
  • S&P Futures

    4,392.00
    -11.00 (-0.25%)
     
  • Dow Futures

    34,852.00
    -99.00 (-0.28%)
     
  • Nasdaq Futures

    15,065.25
    -32.75 (-0.22%)
     
  • Russell 2000 Futures

    2,204.40
    -0.70 (-0.03%)
     
  • Crude Oil

    71.93
    -0.14 (-0.19%)
     
  • Gold

    1,803.40
    +1.60 (+0.09%)
     
  • Silver

    25.32
    +0.09 (+0.34%)
     
  • EUR/USD

    1.1784
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.2610
    -0.0250 (-1.94%)
     
  • Vix

    18.56
    +0.87 (+4.92%)
     
  • GBP/USD

    1.3779
    +0.0025 (+0.18%)
     
  • USD/JPY

    110.3790
    -0.1310 (-0.12%)
     
  • BTC-USD

    38,623.89
    +4,313.97 (+12.57%)
     
  • CMC Crypto 200

    924.65
    +130.92 (+16.49%)
     
  • FTSE 100

    7,023.28
    -4.30 (-0.06%)
     
  • Nikkei 225

    27,833.29
    +285.29 (+1.04%)
     

What Percentage Of Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Do Insiders Own?

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

A look at the shareholders of Utah Medical Products, Inc. (NASDAQ:UTMD) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.

With a market capitalization of US$324m, Utah Medical Products is a small cap stock, so it might not be well known by many institutional investors. In the chart below, we can see that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about Utah Medical Products.

Check out our latest analysis for Utah Medical Products

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Utah Medical Products?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Utah Medical Products already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Utah Medical Products' historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. It looks like hedge funds own 6.8% of Utah Medical Products shares. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Our data shows that FMR LLC is the largest shareholder with 15% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 7.7% and 6.8%, of the shares outstanding, respectively. Furthermore, CEO Kevin Cornwell is the owner of 5.2% of the company's shares.

We did some more digging and found that 7 of the top shareholders account for roughly 50% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

Insider Ownership Of Utah Medical Products

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

I can report that insiders do own shares in Utah Medical Products, Inc.. As individuals, the insiders collectively own US$22m worth of the US$324m company. This shows at least some alignment. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public, with a 20% stake in the company, will not easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important.

I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.